Woodline Partners’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Woodline Partners’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell
2023 Q1	$34M	Buy
2022 Q4	$34.3M	Buy
2022 Q3	$16.4M	Sell
2022 Q2	$33.6M	Buy
2022 Q1	$17M	Buy
2021 Q4	$9.9M	Buy
2021 Q3	$4.92M	Buy
2021 Q2	$4.98M	Sell
2021 Q1	$3.84M	Buy